NO995035L - 5,6,7-trisubstituerte-4-aminopyrido[2,3- D]pyrimidinforbindelser - Google Patents
5,6,7-trisubstituerte-4-aminopyrido[2,3- D]pyrimidinforbindelserInfo
- Publication number
- NO995035L NO995035L NO995035A NO995035A NO995035L NO 995035 L NO995035 L NO 995035L NO 995035 A NO995035 A NO 995035A NO 995035 A NO995035 A NO 995035A NO 995035 L NO995035 L NO 995035L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- aminopyrido
- trisubstituted
- pyrimidine compounds
- mammal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Forbindelse som har formel (II) iVrR< ^ ifr^- L \r^- ta 5 (10 hvor R1, R2, R3, R4 og R5 er definert, en fremgangsmåte ved inhibering av adenosinkinase ved å administrere en for- bindelse derav, en farmasøytisk sammensetning omfattende en terapeutisk effektiv mengde av en forbindelse derav oven- for, i kombinasjon med en farmasøytisk akseptabel bærer, en fremgangsmåte ved behandling av cerebral iskemi, epilepsi, smerte, nocipersepsjon, inflammasjon og sepsis i et patte- dyr som trenger slik behandling, omfattende å administrere til pattedyret en terapeutisk effektiv mengde av en for- bindelse derav, og fremgangsmåter ved fremstilling derav.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84348497A | 1997-04-16 | 1997-04-16 | |
| PCT/US1998/007201 WO1998046604A1 (en) | 1997-04-16 | 1998-04-13 | 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995035D0 NO995035D0 (no) | 1999-10-15 |
| NO995035L true NO995035L (no) | 1999-12-15 |
Family
ID=25290123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995035A NO995035L (no) | 1997-04-16 | 1999-10-15 | 5,6,7-trisubstituerte-4-aminopyrido[2,3- D]pyrimidinforbindelser |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0975633A1 (no) |
| JP (1) | JP2001520654A (no) |
| KR (1) | KR20010006462A (no) |
| CN (1) | CN1252069A (no) |
| AR (1) | AR012437A1 (no) |
| AU (1) | AU741033B2 (no) |
| BG (1) | BG103853A (no) |
| BR (1) | BR9809056A (no) |
| CA (1) | CA2286592A1 (no) |
| CO (1) | CO4940470A1 (no) |
| HU (1) | HUP0001443A3 (no) |
| IL (1) | IL131617A0 (no) |
| NO (1) | NO995035L (no) |
| NZ (1) | NZ337125A (no) |
| PL (1) | PL336265A1 (no) |
| SK (1) | SK140099A3 (no) |
| TR (1) | TR199902550T2 (no) |
| WO (1) | WO1998046604A1 (no) |
| ZA (1) | ZA983175B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001057040A1 (en) * | 2000-02-03 | 2001-08-09 | Abbott Laboratories | 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
| WO2002064594A2 (en) | 2001-02-12 | 2002-08-22 | F. Hoffmann-La Roche Ag | 6-substituted pyrido-pyrimidines |
| CN107744520A (zh) * | 2017-10-25 | 2018-03-02 | 南京多宝生物科技有限公司 | 嘧啶类化合物在制备促进小肠蠕动药物中的应用 |
| CN112209924B (zh) * | 2019-07-09 | 2022-04-05 | 中国科学院天津工业生物技术研究所 | 选择性腺苷a1受体拮抗剂 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB774094A (en) * | 1953-01-02 | 1957-05-08 | Wellcome Found | Improvements in or relating to pyrimidine compounds |
| IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
-
1998
- 1998-04-13 WO PCT/US1998/007201 patent/WO1998046604A1/en not_active Application Discontinuation
- 1998-04-13 JP JP54408398A patent/JP2001520654A/ja active Pending
- 1998-04-13 NZ NZ337125A patent/NZ337125A/en unknown
- 1998-04-13 EP EP98918091A patent/EP0975633A1/en not_active Withdrawn
- 1998-04-13 IL IL13161798A patent/IL131617A0/xx unknown
- 1998-04-13 KR KR1019997009552A patent/KR20010006462A/ko not_active Application Discontinuation
- 1998-04-13 PL PL98336265A patent/PL336265A1/xx unknown
- 1998-04-13 TR TR1999/02550T patent/TR199902550T2/xx unknown
- 1998-04-13 BR BR9809056-9A patent/BR9809056A/pt not_active IP Right Cessation
- 1998-04-13 SK SK1400-99A patent/SK140099A3/sk unknown
- 1998-04-13 AU AU71080/98A patent/AU741033B2/en not_active Ceased
- 1998-04-13 HU HU0001443A patent/HUP0001443A3/hu unknown
- 1998-04-13 CN CN98804117A patent/CN1252069A/zh active Pending
- 1998-04-13 CA CA002286592A patent/CA2286592A1/en not_active Abandoned
- 1998-04-15 ZA ZA983175A patent/ZA983175B/xx unknown
- 1998-04-15 AR ARP980101734A patent/AR012437A1/es unknown
- 1998-04-16 CO CO98020978A patent/CO4940470A1/es unknown
-
1999
- 1999-10-15 NO NO995035A patent/NO995035L/no not_active Application Discontinuation
- 1999-11-03 BG BG103853A patent/BG103853A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG103853A (en) | 2000-06-30 |
| KR20010006462A (ko) | 2001-01-26 |
| HUP0001443A3 (en) | 2001-01-29 |
| IL131617A0 (en) | 2001-01-28 |
| PL336265A1 (en) | 2000-06-19 |
| CN1252069A (zh) | 2000-05-03 |
| EP0975633A1 (en) | 2000-02-02 |
| AU741033B2 (en) | 2001-11-22 |
| BR9809056A (pt) | 2000-08-01 |
| HUP0001443A2 (hu) | 2000-10-28 |
| CO4940470A1 (es) | 2000-07-24 |
| WO1998046604A1 (en) | 1998-10-22 |
| SK140099A3 (en) | 2000-05-16 |
| JP2001520654A (ja) | 2001-10-30 |
| TR199902550T2 (xx) | 2000-04-21 |
| ZA983175B (en) | 1998-10-21 |
| NO995035D0 (no) | 1999-10-15 |
| AR012437A1 (es) | 2000-10-18 |
| NZ337125A (en) | 2001-06-29 |
| CA2286592A1 (en) | 1998-10-22 |
| AU7108098A (en) | 1998-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2150123A1 (en) | Aminomethylene substituted non-aromatic heterocycles | |
| CA2098076A1 (en) | Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates | |
| CA2293823A1 (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
| CA2258548A1 (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
| BG100635A (en) | Substituted n-/indol-2-carbonyl/- - alanineamides and their derivatives as antidiabestic preparations | |
| MY116915A (en) | Substituted indazole analogs | |
| WO1998022493A3 (en) | N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS | |
| NO984470L (no) | Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase | |
| CA2107223A1 (en) | Crystalline tiagabine hydrochloride monohydrate, its preparation and use | |
| NO20001169L (no) | 6,9-bro erythromycinderivater | |
| CA2286511A1 (en) | Novel macrolide derivatives | |
| NO20002099L (no) | 6,11-bro-erytromycinderivater | |
| BG104340A (en) | 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity | |
| NO995036L (no) | 5,7-disubstituerte 4-aminopyrido[2,3-d]pyrimidinforbindelser og deres anvendelse som adenosinkinaseinhibitorer | |
| EP1142881A4 (en) | POLY (ADP-RIBOSE) POLYMERASE INHIBITORS CONSISTING OF PYRIMIDINE DERIVATIVES | |
| NO995035L (no) | 5,6,7-trisubstituerte-4-aminopyrido[2,3- D]pyrimidinforbindelser | |
| DE69122858D1 (de) | Therapeutische benzazepin verbindungen | |
| KR100853955B1 (ko) | 아크릴로일 디스타마이신 유도체 및 국소이성화효소 ⅰ 및ⅱ 억제제를 포함하는 약제학적 조성물 | |
| NO995033L (no) | 6,7-disubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser | |
| WO1990012577A3 (en) | Topical anti-angiogenic as hair growth inhibitors | |
| AP9801235A0 (en) | Erythromycin derivatives. | |
| CA2208032A1 (en) | Substituted amidinonaphthyl ester derivative | |
| MX9604692A (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
| AU6919398A (en) | Heterocyclic compounds and their preparation and use | |
| MXPA98005355A (es) | Derivados de 5-[(heteroaril) alquil]-3 -oxo-pirido [1, 2-a]bencimidazol -4-carboxamida utiles en el tratamiento de trastornos del sistema nervioso central. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |